ARK Genomic Revolution ETF
ARKG
1 hedge funds and large institutions have $343K invested in ARK Genomic Revolution ETF in 2015 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 2 closing their positions.
4.28% less ownership
Funds ownership: 8.8% → 4.51% (-4.3%)
58% less capital invested
Capital invested by funds: $821K → $343K (-$478K)
67% less funds holding
Funds holding: 3 → 1 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$364K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$13K |
| 3 |
Wells Fargo
San Francisco,
California
|
-$1K |
ARKG Hedge Fund Activity: Q3 2015 in Review
1 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in ARK Genomic Revolution ETF (ARKG) for Q3 2015, worth a combined $343K — down 58% from $821K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of ARKG and 0 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 0 added.
The largest seller was Jane Street, cutting an estimated $364K.
- 1 institutional investor held ARK Genomic Revolution ETF (ARKG) as of Q3 2015, down from 3 in Q2 2015.
- Funds reported $343K of ARK Genomic Revolution ETF stock for Q3 2015, down 58% quarter-over-quarter.
- 0 funds opened new ARK Genomic Revolution ETF positions in Q3 2015 and 2 closed out, a net change of -2 holders.
- The largest ARK Genomic Revolution ETF seller in Q3 2015 was Jane Street, an estimated $364K sold.
Based on aggregated 13F filings for Q3 2015.